Differences on the contribution of specific components of the metabolic syndrome between hypertensive Latin American and Spanish patients

被引:6
作者
de la Sierra, Alejandro [1 ]
Piskorz, Daniel [1 ]
Plavnik, Frida [1 ]
Saavedra, Leonardo [1 ]
机构
[1] Hosp Clin Barcelona, Med Interna Serv, Barcelona, Spain
来源
MEDICINA CLINICA | 2009年 / 133卷 / 02期
关键词
Metabolic syndrome; Abdominal obesity; Differences among world regions; Cardiometabolic risk; 3RD NATIONAL-HEALTH; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; RISK-FACTORS; ALL-CAUSE; PREVALENCE; MANAGEMENT; MORTALITY; ASSOCIATION;
D O I
10.1016/j.medcli.2009.01.034
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and objective: The aim of the present study was to evaluate possible differences in the impact of the components of metabolic syndrome (MS) on hypertensive patients from countries in Latin America and Spain. Patients and method: Cross-sectional study in 632 hypertensives with MS recruited in Argentina, Brazil, Spain, Mexico, Chile, Venezuela and Colombia. Demographic and clinical data, as well as the impact of every single component of the MS were evaluated and compared depending on the country they came from. Results: Mean age was 55(14) years, with 54% females. Thirty-eight percent presented 3 MS criteria, 40% presented 4 criteria, and 22% all the 5 criteria. There were no differences among countries in relation to triglyceride mean values. Subjects from Brazil, Mexico, and Spain showed the highest values of fasting plasma glucose. Women from Venezuela and Brazil showed the highest values of waist circumference and women from Venezuela and Chile the lowest values of HDL-cholesterol. With respect to the proportion of patients with each component alteration, those from Venezuela showed the highest proportion of hypertriglyceridemia (83%) and low HDL-cholesterol (77%), whereas those from Spain exhibited the lowest (56% and 40%). Conclusions: The impact of the components of MS is relatively homogeneous in Latin-America and Spain. However, some differences are detected, with atherogenic dyslipidemia being the predominant factor in Venezuela and abnormal fasting plasma glucose the main one in Spain. (C) 2008 Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:47 / 52
页数:6
相关论文
共 27 条
[1]  
Barbosa Paulo José Bastos, 2006, Arq. Bras. Cardiol., V87, P407, DOI 10.1590/S0066-782X2006001700003
[2]  
CIRUZZI M, 1996, REV ARGENT CARDIOL, V64, P1
[3]   Metabolic syndrome and target organ damage in untreated essential hypertensives [J].
Cuspidi, C ;
Meani, S ;
Fusi, V ;
Severgnini, B ;
Valerio, C ;
Catini, E ;
Leonetti, G ;
Magrini, F ;
Zanchetti, A .
JOURNAL OF HYPERTENSION, 2004, 22 (10) :1991-1998
[4]   Prevalence and general features of the metabolic syndrome in the Spanish hypertensive population [J].
de la Sierra, A ;
Romero, R ;
Bonet, J ;
Pérez, M ;
López, JS ;
Ravella, R ;
Aguilera, MT .
MEDICINA CLINICA, 2006, 126 (11) :406-409
[5]   Evaluation and management of hypertension in Spain.: A consensus guide [J].
de la Sierra, Alejandro ;
Gorostidi, Manuel ;
Marin, Rafael ;
Redon, Josep ;
Banegas, Jose R. ;
Armario, Pedro ;
Puig, Juan Garcia ;
Zarco, Julio ;
Llisterri, Jose L. ;
Sanchis, Carlos ;
Abarca, Benjamin ;
Palomo, Vicente ;
Gomis, Ramon ;
Otero, Alfonso ;
Villar, Fernando ;
Honorato, Jesus ;
Tamargo, Juan ;
Lobos, Jose M. ;
Macias-Nunez, Juan ;
Sarria, Antonio ;
Aranda, Pedro ;
Ruilope, Luis M. .
MEDICINA CLINICA, 2008, 131 (03) :104-116
[6]  
de la Sierra Alejandro, 2007, Cardiovascular & Hematological Agents in Medicinal Chemistry, V5, P209
[7]   Abdominal obesity and metabolic syndrome [J].
Despres, Jean-Pierre ;
Lemieux, Isabelle .
NATURE, 2006, 444 (7121) :881-887
[8]   Preventing cardiovascular disease and diabetes - A call to action from the American Diabetes Association and the American Heart Association [J].
Eckel, Robert H. ;
Kahn, Richard ;
Robertson, Rose Marie ;
Rizza, Robert A. .
DIABETES CARE, 2006, 29 (07) :1697-1699
[9]   Prevalence of the metabolic syndrome among US adults - Findings from the Third National Health and Nutrition Examination Survey [J].
Ford, ES ;
Giles, WH ;
Dietz, WH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (03) :356-359
[10]   Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome - A summary of the evidence [J].
Ford, ES .
DIABETES CARE, 2005, 28 (07) :1769-1778